These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8517426)

  • 1. Comparison of bisoprolol with atenolol for systemic hypertension in four population groups (young, old, black and nonblack) using ambulatory blood pressure monitoring. Bisoprolol Investigators Group.
    Neutel JM; Smith DH; Ram CV; Lefkowitz MP; Kazempour MK; Weber MA
    Am J Cardiol; 1993 Jul; 72(1):41-6. PubMed ID: 8517426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents.
    Neutel JM; Smith DH; Ram CV; Kaplan NM; Papademetriou V; Fagan TC; Lefkowitz MP; Kazempour MK; Weber MA
    Am J Med; 1993 Feb; 94(2):181-7. PubMed ID: 8430713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisoprolol and atenolol in essential hypertension: effects on systemic and renal hemodynamics and on ambulatory blood pressure.
    Leeman M; van de Borne P; Collart F; Vandenhoven G; Peeters L; Mélot C; Degaute JP
    J Cardiovasc Pharmacol; 1993 Dec; 22(6):785-91. PubMed ID: 7509894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind comparison of bisoprolol and atenolol in patients with essential hypertension.
    Wheeldon NM; MacDonald TM; Prasad N; Maclean D; Peebles L; McDevitt DG
    QJM; 1995 Aug; 88(8):565-70. PubMed ID: 7648243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of once-daily atenolol and metoprolol using office and ambulatory blood pressure monitoring.
    Rutan GH; Feig PU; May S; Kriegman AG; Brady EM
    J Clin Pharmacol; 1993 May; 33(5):418-26. PubMed ID: 8331198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized double-blind study of bisoprolol versus atenolol in mild to moderate essential hypertension.
    Dixon MS; Thomas P; Sheridan DJ
    Eur J Clin Pharmacol; 1990; 38(1):21-4. PubMed ID: 1970298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled study on the effects of bisoprolol and atenolol on sympathetic nervous activity and central aortic pressure in patients with essential hypertension.
    Zhou WJ; Wang RY; Li Y; Chen DR; Chen EZ; Zhu DL; Gao PJ
    PLoS One; 2013; 8(9):e72102. PubMed ID: 24039738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of bisoprolol and atenolol in the treatment of mild to moderate hypertension.
    Lewis R; Maclean D; Ioannides C; Johnston A; McDevitt DG
    Br J Clin Pharmacol; 1988 Jul; 26(1):53-9. PubMed ID: 2904825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive effects of beta-blockers administered once daily: 24-hour measurements.
    Neutel JM; Schnaper H; Cheung DG; Graettinger WF; Weber MA
    Am Heart J; 1990 Jul; 120(1):166-71. PubMed ID: 2360502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of antihypertensive effect by blood pressure monitoring: applications to bisoprolol and lisinopril in a double-blind study.
    Vaïsse B; Herpin D; Asmar R; Battistella P; Zannad F; Boutelant S; Lyon A; Conte D; Denis J; Honore P; Contard S; Prost PL; Mallion JM; Poggi L
    J Cardiovasc Pharmacol; 1997 May; 29(5):612-7. PubMed ID: 9213203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind comparison of the cardioselective beta-blockers bisoprolol and atenolol in hypertension: the Bisoprolol International Multicenter Study (BIMS).
    Bühler FR; Berglund G; Anderson OK; Brunner HR; Scherrer U; van Brummelen P; Distler A; Philipp T; Fogari R; Mimran A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S122-7. PubMed ID: 2439782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atenolol and bisoprolol in the treatment of mild and moderately severe hypertension].
    Soucek M; Prásek J; Spinarová L
    Vnitr Lek; 1993 Jun; 39(6):541-8. PubMed ID: 8212607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study.
    Lithell H; Selinus I; Hosie J; Frithz G; Weiner L
    Eur Heart J; 1987 Dec; 8 Suppl M():55-64. PubMed ID: 2967186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).
    Hiltunen TP; Suonsyrjä T; Hannila-Handelberg T; Paavonen KJ; Miettinen HE; Strandberg T; Tikkanen I; Tilvis R; Pentikäinen PJ; Virolainen J; Kontula K
    Am J Hypertens; 2007 Mar; 20(3):311-8. PubMed ID: 17324745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized placebo-controlled comparison of amlodipine and atenolol in mild to moderate systemic hypertension.
    Frishman WH; Brobyn R; Brown RD; Johnson BF; Reeves RL; Wombolt DG
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S103-6. PubMed ID: 2467116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effects of bisoprolol and atenolol on lipoprotein concentrations and blood pressure.
    Lithell H; Weiner L; Selinus I; Vessby B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S128-33. PubMed ID: 2439783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, safety, and effects on quality of life of bisoprolol/hydrochlorothiazide versus amlodipine in elderly patients with systolic hypertension.
    Benetos A; Consoli S; Safavian A; Dubanchet A; Safar M
    Am Heart J; 2000 Oct; 140(4):E11. PubMed ID: 11011336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of atenolol versus bisoprolol with noninvasive hemodynamic and pulse wave assessment.
    Aparicio LS; Alfie J; Barochiner J; Cuffaro PE; Giunta DH; Elizondo CM; Tortella JJ; Morales MS; Rada MA; Waisman GD
    J Am Soc Hypertens; 2015 May; 9(5):390-6. PubMed ID: 25816713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.